التفاصيل البيبلوغرافية
العنوان: |
1224PD - Analysis of response and survival in patients (pts) with ipilimumab (ipi)-refractory melanoma treated with pembrolizumab (pembro) in KEYNOTE-002 |
المؤلفون: |
Daud, A., Puzanov, I., Dummer, R., Schadendorf, D., Hamid, O., Robert, C., Hodi, F.S., Schachter, J., Sosman, J., Pavlick, A.C., Gonzalez, R., Blank, C.U., Cranmer, L., O’Day, S.J., Salama, A.K., Margolin, K., Yang, J., Homet Moreno, B., Ibrahim, N., Ribas, A. |
المصدر: |
In Annals of Oncology September 2017 28 Supplement 5:v434-v434 |
قاعدة البيانات: |
ScienceDirect |